Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, includ...
Oct 7, 2025, 10:38 AM EDT - 18 days ago
Oct 7, 2025, 9:44 AM EDT - 18 days ago
Oct 6, 2025, 8:00 AM EDT - 19 days ago
Sep 15, 2025, 7:00 AM EDT - 5 weeks ago